首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CD22 Recombinant Antibody(Epratuzumab)

Anti-Human CD22 Recombinant Antibody(Epratuzumab)

产品编号

YR1021

别名

科研级 Epratuzumab ( 依帕珠单抗 ), Anti-CD22 Recombinant Antibody, Research Grade Epratuzumab

规格
  • 1mg
  • 5mg
产品介绍
Catalog NumberYR1021
Alias科研级 Epratuzumab ( 依帕珠单抗 ), Anti-CD22 Recombinant Antibody, Research Grade Epratuzumab
Size1mg, 5mg
Molecular NameEpratuzumab
CAS Number205923-57-5
TargetCD22[Homo sapiens]
HostMouse
Antibody IsotypeIgG1
ClonityMonoclonal
Concentration1mg/ml
Purity>95% as determined by SDS-PAGE
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
FormulationPBS, pH7.5
Shipping ConditionShipped on ice packs.
BackgroundEpratuzumab (planned trade name LymphoCide) is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as systemic lupus erythematosus (SLE).
ApplicationIF, IP, Neut, FuncS, ELISA, FCM, ICC, Activ, WB
RemarksThis product is for research use only.

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价